Surviving CTIMPs and MHRA inspections Kim Gooding Diabetes and Vascular Medicine UEMS and Exeter CRF Exeter Clinical Research Facility.

Slides:



Advertisements
Similar presentations
CMRSC Division of Hematology/Oncology
Advertisements

Briefing on MHRA routine inspection of non-commercial clinical trials
Research Policy & Management RACD INTRODUCTION TO RESEARCH GOVERNANCE.
Essential Documentation GCP Training Seminar 12th October 2011
Medicines and Healthcare products Regulatory Agency (MHRA) Statutory Good Clinical Practice (GCP) Inspection of Cardiff University.
Timelines Trust informed June 2007
Tips to a Successful Monitoring Visit
New Trials If you are seeking a collaboration with the UCL CCTU we require you to apply: At least 3 months before the application deadline By using the.
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
Working together for better Research - Collaborative research with BCUHB Dr Nefyn Williams & Dr Richard Tranter, NWORTH Associate Clinical Directors &
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Management Through Systems Vicki Latter Biomedicine Research & Development Unit University College London.
Practical Effective Steps to Improve Trial QUALITY from Audit/Inspections findings Cancer Clinical Trials Unit Scotland A NCRI Accredited Cancer Trials.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Managing Sponsorship Research Services University of Oxford.
Notice of Compliance Audit
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
1 Are we ready for an audit/inspection as a CRO? Clinical Research Association Istanbul – 01DEC2007 Tony Owen, Vice-President QA Europe.
Medication Safety Standard 4 Part 3 – Documentation of Patient Information, Continuity of Medication Management Margaret Duguid, Pharmaceutical Advisor.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Establish Documentation and Record Keeping (Task 12 / Principle 7)
Unit 2: Managing the development of self and others Life Science and Chemical Science Professionals Higher Apprenticeships Unit 2 Managing the development.
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Introduction to ISO New and modified requirements.
A S Nanivadekar Introduction to GCP. A S Nanivadekar Outline Definition and scope Definition and scope Purpose of clinical research Purpose of clinical.
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Facilitator: Sheila Douglas. Envision Training
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
. (Agathe Guillot - GCP Inspector, 14 July 2014) MHRA view of responsible Sponsorship.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a’r Fro NHS R&D Overview How to avoid the common pitfalls? Thomas Fairman Research Liaison Manager.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
Aged Care and Home and Community Care. Step 1: Analyse the application. Identify any key questions for competency conversation. Step 5: Identify any.
Validation | Slide 1 of 27 August 2006 Validation Supplementary Training Modules on Good Manufacturing Practice WHO Technical Report Series, No. 937, 2006.
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Site Monitoring Shirley Frederiksen Donna Harsh.
A QUALITY IMPROVEMENT TOOL
Compliance Monitoring and Enforcement Audit Program - The Audit Process.
Sponsor Visits and Monitoring
Discharge Summaries.  Discharge Summaries –Can be challenging  What happens during a hospital course is now more complex and more detailed than in the.
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Welcome. Registration complete? CQC Inspection visit Routine Responsive Themed.
Quality & Regulatory Expectations of Outsourcing Oversight Nicky Dodsworth, VP Global Quality Assurance.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
A single approval for research in the NHS Wendy Fisher Research Applications Limited.
Good Laboratory Practice - general information Pirkko Puranen Senior Inspector, Ph.D. Inspectorate.
Responsibilities of Test Facility Management, Study Director, Principal Investigator and Study Personnel G. Jacobs Belgian GLP Monitorate Zagreb, 17 December.
Site Set-up and Conduct Caroline O’Leary and Carrie Bayliss.
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
Briefing on MHRA routine inspection of non-commercial clinical trials
Remote Site Initiation Visits
Responsibilities of Sponsor, Investigator and Monitor
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S SITE FILE
Administering Informed Consent Issues for Discussion
Good Clinical Practice (GCP) requirements for ANODE
Introduction to Internal Audits
End of Year Performance Review Meetings and objective setting for 2018/19 This briefing pack is designed to be used by line managers to brief their teams.
Quality Control SOP 3.12 Release Date: 08/10/2015.
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Consent and eligibility for Clinical Trials: Learning Burst 4
How to conduct Effective Stage-1 Audit
Quality Audits, and How to Survive them
Steps towards Certification
Good clinical practice
Fed-IP Assessor Training: Module 3 Assessing an application for Fed-IP
S A Overarching SOPs Funding Secured Training Records
Presentation transcript:

Surviving CTIMPs and MHRA inspections Kim Gooding Diabetes and Vascular Medicine UEMS and Exeter CRF Exeter Clinical Research Facility

My CTIMP history Principal Investigator (PI) on 2 investigator led studies – Both out of licence use of the IMP (drug) – One low risk, mechanistic study – Acute, clinical setting Non-commercial studies, both sponsored by R&D Both selected for inspection by MHRA

Is the proposed study a CTIMP?

How do you check whether it is a CTIMP? Talk to people, eg other researcher, R&D Send protocols for MHRA Algorithim – /uploads/attachment_data/file/317952/Algothrim.pdf

Algorithm

Is it CTIMP? MHRA interested in studies looking at safety, efficacy and new indications for drugs. Tend not to be interested in mechanistic studies Are you testing the drug or using it as a research tool? Is it clear from your research question / aim that you are using the drug as a research tool?

Research question Interested in whether an abnormal peak skin blood flow response is induced by inflammation. Does the Salmonella typhi vaccination induces a abnormal peak reactive hyperaemic response in healthy individuals? To examine whether an acute inflammatory challenge induces abnormal vascular response in healthy individuals.

Study Development Talk to people

Study development Ensure that protocol is agreed with all relevant parties prior to submission, includes study team, sponsor and the clinical trials pharmacy team. IMP pathway Source data Safety reporting

Delegation of responsibilities Between Co-sponsors eg Trust and University Between sponsors and CI / PI Between CI and PI

Clinical trials authorisation Submitted at the same time as Research Ethics submission. Can be difficult to information before you are in system.

During the study Keep your site file up to date – Delegation logs – Summary product of characteristics Ensure that all relevant information is signposted. Document everything – Document phone calls by confirmation s or files notes. Easier and more accurate to do it as you go along

My inspection experience

Panic!!!!!!!

Preparation for MHRA inspection Ensure site folder is up to date, signposted and complete Use file notes to complete the story Ensure all CRFs are appropriately completed Hospital notes contain all relevant details.

Lots of paperwork and communication with the research team and Trust, including a last minute audit Take advantage of all training / preparation eg I attended the Trust run courses: Inspection readiness and Mock interview Keep the study team informed Preparation for MHRA inspection

Ensure all process are in place, including – SOPs – Risk assessments – Freezer monitoring – All equipment under appropriate QC – GCP and training records – Honorary contracts

Prior to inspection Submitted site files, all CRFs and hospital notes, CVs of PI and CI Submitted information on training processes Training records of staff members performing assigned assessments /procedures.

During the inspection Attended the initial open briefing by Inspector Underwent my scheduled interview. Be prepared to supply additional information as required. – Ensure that you have time available or a runner Be prepared to attend a second interview Attended the final, close out meeting

Interview They use a variety of techniques, for example silence and double questioning. Main advice – Know your study – Know your study role – Be honest Ask questions, use it as a learning experience

Main feedback from first inspection Insufficient documentation Training: documented proof of training and competency. Delegation log is not sufficient. – Certificates – Training records Calibration / QC data: Evident that we are performing robust calibrations and QC checks but the documentation of this is not sufficient.

Documenting QC / calibration data Each individual machine needs a dedicated QC sheet. The sheet should reference relevant SOP. It should also include information on acceptable values. Should be signed and dated by operator. Should also be ultimately be signed off / reviewd by a competent individual.

Equipment / software etc Is everything validated? Does it fulfil IQ OQ PQ – IQ: Installation quality installed correctly? – OQ: Operational quality working correctly? – PQ: Performance quality performing as expected? – Cross Equipment verification

Take home messages Is the proposed study a CTIMP? Talk to people from the outset – Pharmacy, R&D, Sponsors, study team …….. – Team endeavour Document everything – File notes are wonderful things!

Don’t be put off from doing a study if it is a CTIMP.

Acknowledgements Diabetes and Vascular Medicine Research Team Stroke Research Team Pharmacy Clinical Trials Unit R&D